NEMLUVIO RESOURCES

Essential tools to help you along the way

Not an actual patient.
Patient brochure for NEMLUVIO® (nemolizumab-ilto).

Your Guide to NEMLUVIO

Whether you are considering NEMLUVIO® or are already beginning treatment, this detailed guide helps support your experience with NEMLUVIO at every stage.

Download patient brochure  

Dermatologist discussion guide.

Dermatologist Discussion Guide

Assess the impact of itch on your life to help lead more meaningful conversations with a dermatologist about prurigo nodularis (PN) and NEMLUVIO.

Download Discussion guide  

NEMLUVIO® (nemolizumab-ilto) Instructions for Use.

Instructions for Use

Read before using NEMLUVIO and carefully follow the steps.

Download Instructions for use  

Welcome Kit box.

Support at every turn

From the moment you start NEMLUVIO, support is at your fingertips—and continues all along the way. By signing up, you'll receive our ongoing guidance and helpful materials, like the Welcome Kit, to ensure you have what you need.

Sign Up for Support  

Your skin deserves specialized care

Working with a trusted dermatologist is essential to achieving itch relief and treatment success. Use the National Eczema Association search tool to find local dermatologists who can help determine the best option for you.

Find a Dermatologist  

Not an actual patient.

 

Academic and Advocacy Organizations

It's important to remember you're not alone. Connecting with compassionate communities and gaining insights from others may help you better manage PN. You may even discover you'd like to become an advocate.

STILL HAVE QUESTIONS?

To help make learning simple, we collected the top questions about NEMLUVIO and managing PN.

Important Safety Information

Indication: NEMLUVIO® (nemolizumab-ilto) is a prescription medicine used to treat adults with prurigo nodularis.

Do not take NEMLUVIO if you are allergic to nemolizumab-ilto or to any ingredients in NEMLUVIO.

Before taking NEMLUVIO, tell your healthcare provider about all of your medical conditions, including if you:

  • are scheduled to receive any vaccination. You should not receive a live vaccine right before or during treatment with NEMLUVIO.
  • are pregnant or plan to become pregnant. It is not known whether NEMLUVIO will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known whether NEMLUVIO passes into your breast milk and if it can harm your baby.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

NEMLUVIO may cause serious side effects, including: allergic reactions (hypersensitivity). Stop using NEMLUVIO and tell your healthcare provider or get emergency help right away if you get any of the following symptoms:

  • Breathing problems or wheezing
  • Swelling of the face, lips, mouth, tongue, or throat
  • Fainting, dizziness, feeling lightheaded
  • Fast pulse
  • Swollen lymph nodes
  • Joint pain
  • Fever
  • Skin rash (red or rough skin)
  • Nausea or vomiting
  • General ill feeling
  • Cramps in your stomach area

The most common side effects of NEMLUVIO include:

  • Headache
  • Skin rashes: atopic dermatitis (a type of eczema), eczema, and eczema nummular (scattered circular patches)

These are not all of the possible side effects of NEMLUVIO.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1‑800‑FDA‑1088.

Please see full Prescribing Information, including Patient Information.